Enliven Therapeutics (ELVN) Earnings Date, Estimates & Call Transcripts → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free ELVN Stock Alerts $24.41 +0.98 (+4.18%) (As of 11:14 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 14EstimatedActual EPS (Mar. 14) -$0.47 Beat By $0.09 Consensus EPS (Mar. 14) -$0.56 Get Enliven Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ELVN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueELVN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ELVN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Enliven Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.16) EPSNext Year EPS Consensus Estimate: ($2.81) EPSELVN Earnings Date and InformationEnliven Therapeutics last posted its earnings data on March 14th, 2024. The reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($0.56) by $0.09. Enliven Therapeutics has generated ($2.19) earnings per share over the last year (($2.19) diluted earnings per share). Earnings for Enliven Therapeutics are expected to decrease in the coming year, from ($2.16) to ($2.81) per share. Read More Enliven Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/14/2024Q4 2023($0.56)($0.47)+$0.09($0.47)--11/9/2023Q3 2023($0.49)($0.51)($0.02)($0.51)--8/10/2023Q2 2023($0.40)($0.41)($0.01)($0.41)--5/11/2023Q1 2023($0.67)($0.80)($0.13)($0.80)--2/10/2023Q4 2022-$4.92+$4.92$4.92--10/25/2022Q3 2022-($0.72)($0.72)($0.72)-- Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022($2.24)($1.76)+$0.48($1.76)--5/6/2022Q1 2022($2.28)($2.24)+$0.04($2.24)--3/15/2022Q4 2021($3.16)($2.12)+$1.04($2.12)--11/9/2021Q3 2021($3.64)($2.20)+$1.44($2.20)--8/6/2021Q2 2021($3.08)($2.96)+$0.12($2.96)-- Enliven Therapeutics Earnings - Frequently Asked Questions When did Enliven Therapeutics announce their last quarterly earnings? Enliven Therapeutics (NASDAQ:ELVN) last announced its quarterly earning data on Thursday, March 14, 2024. Learn more on ELVN's earnings history. Did Enliven Therapeutics beat their earnings estimates last quarter? In the previous quarter, Enliven Therapeutics (NASDAQ:ELVN) reported ($0.47) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.09. Learn more on analysts' earnings estimate vs. ELVN's actual earnings. How much profit does Enliven Therapeutics generate each year? Enliven Therapeutics (NASDAQ:ELVN) has a recorded net income of -$71.58 million. ELVN has generated -$2.19 earnings per share over the last four quarters. What is Enliven Therapeutics's EPS forecast for next year? Enliven Therapeutics's earnings are expected to decrease from ($2.16) per share to ($2.81) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ABCL Earnings Date VRNA Earnings Date MNKD Earnings Date COLL Earnings Date MIRM Earnings Date PCRX Earnings Date SYRE Earnings Date BLTE Earnings Date PRTA Earnings Date GYRE Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:ELVN) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe Crypto 9-5 Escape PlanCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
